|
IPC 2025 to ignite innovation, knowledge & industry synergy paving promising avenues for pharma business
|
|
Nandita Vijaysimha, Bengaluru
December 16 , 2025
|
|
|
The Indian Pharmaceutical Congress (IPC), an annual national forum for the pharmaceutical profession in India, serves as a melting pot for ideas and advancements, enabling professionals to stay at the forefront of emerging trends, regulatory developments, and scientific breakthroughs.
Prof. Milind Umekar, president, Association of Pharmaceutical Teachers of India (APTI) and president, Indian Pharmaceutical Congress Association (IPCA), pointed out that the 74th IPC from December 19-21, at the Bengaluru Intentional Exhibition Centre (BIEC), Bengaluru is expected to attract over 8,000 delegates from across India and abroad, making it a vibrant confluence of scientific thought, professional networking, and collaborative opportunities.
Organized under the aegis of IPCA, and hosted by APTI, the 74th edition of IPC brings together academicians, researchers, industry leaders, regulators, healthcare professionals, and students to exchange knowledge, display innovation, and deliberate on the future of pharmacy and healthcare. It will highlight India’s growing leadership in pharmaceuticals, biotechnology, healthcare research, and regulatory science.
From digitalized pharmaceutical manufacturing to drug delivery systems like transdermal patches, osmotic pumps, stimuli-responsive systems, and intranasal/pulmonary delivery for oncology, diabetes, neurology, genetic disorders, and infectious diseases, the event will showcase advances that are revolutionizing the future of healthcare and pharmaceutical advancements, said Dr. Raman Dang, organizing secretary of 74th IPC.
Also, the three-day exposition will be a dynamic interface between industry and professionals is the Pharma Expo serves as a dynamic interface between industry and professionals, featuring pharmaceutical companies, CROs, CDMOs, equipment manufacturers, and technology providers showcasing the latest innovations. The Education Expo complements this by highlighting advancements in pharmaceutical education, skill development initiatives, research infrastructure, and academic–industry collaborations, noted Dr Dang.
The congress will have Karnataka deputy chief minister DK Shivakumar as the chief patron. His strong commitment to education, innovation, industrial development, and the startup ecosystem lends significant vision and stature to IPC and underscores Karnataka’s role as a leading hub for pharmaceutical and biotechnology advancement, said Dr Dang.
In an effort to garner knowledge, IPC features high-quality scientific sessions including plenary lectures, keynote addresses, symposia, and panel discussions by eminent experts. Poster presentations by delegates are expected to provide a valuable platform for researchers, faculty, and students to present their work, exchange ideas, and receive expert feedback, said Dr Dang.
In today’s dynamic business landscape, where start-ups and new-age entrepreneurs are driving change and innovation, the Pharmathon supports the growth of ground-breaking ideas by offering seed funding, personalized mentorship from successful entrepreneurs, opportunities to showcase prototypes to industry leaders, and pathways to scale concepts into market-ready solutions. All participants receive certificates of achievement for their involvement, said Dr Dang.
With its integrated focus on scientific excellence, industry engagement, education, and innovation, IPC stands as a key driver of progress for the pharmacy profession. Bringing together over 8,000 delegates, the congress strengthens collaboration, nurtures young talent, and contributes meaningfully to national healthcare priorities and India’s global pharmaceutical leadership, said Prof. Umekar.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|